Prof Josephine Forbes is a translational researcher performing bench to bedside studies on novel therapies to prevent type 1 diabetes and a major complication, kidney disease. Currently she based at Mater Research - The University of Queensland in Australia. Josephine is the Australian Diabetes Society President-Elect, the previous chair of the Diabetes Australia Research Program and an editor board member for journals including Kidney International. She is also continually in the top 2% of scientists globally as published annually by Stanford University, with an H index of 62. Josephine has published ~200 research articles with >15000 citations and three patents. She has received numerous prizes for her research including the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research in Australia.

Dr Tan is a senior research fellow at Monash University's Department of Diabetes. She led a research program investigating the pathogenic factors responsible for the onset and progression of diabetic kidney disease. She completed her PhD at the University of Melbourne in 2011 and has since been awarded two JDRF International Postdoctoral Fellowships and a NHMRC Ideas grant. Her current research area focuses on the role of complement in diabetic kidney disease and whether inhibition of complement receptors is renoprotective in preclinical models of diabetes.

Professor Andrew Murphy is the Head of the Division of Inflammation and Immunometabolism at the Baker Heart and Diabetes Institute. He is a CSL Centenary Fellow and a NHMRC Investigator grant recipient. Andrew trained with Prof. Alan Tall’s group at Columbia University as an American Heart Association Fellow. In 2013 he returned to Australia to begin his own group. His work largely focuses on how inflammatory diseases contribute to cardiovascular disease through alterations in haematopoiesis. He has published over 140 manuscripts in leading journals including Nature Medicine, Cell Stem Cell, Cell Metabolism, JCI, etc.

Professor Stephen Twigg, MBBS(Hons-I), PhD(Syd), FRACP, is Head, Dept of Endocrinology, Royal Prince Alfred Hospital (RPAH), Head of Central Clinical School and Kellion Professor of Endocrinology, Stan Clark Chair in Diabetes, in Sydney Medical School and Charles Perkins Centre, the University of Sydney. As a physician-scientist across research lab and clinic, his program since 1995 has been dedicated to preventing and managing end-organ complications in diabetes, including foot disease through the RPAH interdisciplinary Diabetes High Risk Foot Service, and in non-alcoholic steatohepatitis (NASH) in diabetes. He is Co-Chair of NADC Australian Diabetes Foot Network, plus Committee member of Diabetes Feet Australia (DFA), the ADS Diabetes and Liver Disease Subcommittee, DA Kellion Advisory Committee member, and Australian representative on D-Foot International. Steve has published 250+ articles in peer-reviewed journals, mainly in translational research in diabetes and its diabetes complications, having supervised 16 PhD students. His H-factor is 61, with 12,100+ citations. He is a past-President of the Australian Diabetes Society and was bestowed the 2021 Kellion Award. He has led series of ADS Guidelines and Position Statements and delivered national and international presentations in diabetes, including at IDF Global World Congress, ADA Annual Scientific sessions, and in many countries in Asia.